AMY BLAKE: Open Payments
NPI 1467062950 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,599 in 30 payments from 8 companies in 2025. Trend: 2023 $876 · 2024 $3,117 · 2025 $4,599
Consulting: $1,870Travel & lodging: $1,535Food & beverage: $1,106Education: $87
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 20 | $3,875 |
| Janssen Biotech, Inc. | 2 | $209 |
| BeiGene USA, Inc. | 1 | $144 |
| GlaxoSmithKline, LLC. | 1 | $120 |
| Lilly USA, LLC | 1 | $87 |
| Novartis Pharmaceuticals Corporation | 1 | $79 |
| JAZZ PHARMACEUTICALS INC. | 3 | $54 |
| Kite Pharma, Inc. | 1 | $32 |
Products named: AMVUTTRA, BRUKINSA, RYBREVANT, OJJAARA, TALVEY, SCEMBLIX, RYLAZE, Yescarta.
Industry payments across MI — which companies pay providers there.
